^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    NAV-2729

    i
    Other names: NAV-2729
    Associations
    News
    Trials
    Company:
    Navigen, University of Utah
    Drug class:
    ARF6 inhibitor
    Related drugs:
    Associations
    News
    Trials